An interventional study of Exercise and Control in Breast Cancer Survivors and Cognitive Dysfunction, sponsored by University of California, San Diego. Completed at 1 site in United States. Open to female participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by University of California, San Diego · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 1,423 studies in Cognitive Dysfunction with a site in United States — 330 open to participants now, 432 under way, 13 of them phase 3. Cognitive Dysfunction · United States.
Among the 1,423 studies in Cognitive Dysfunction with a site in United States, this one is the 136th largest by enrollment of the 1,147 interventional ones that give a count, is one of 89 that started in 2019, is one of 716 with no phase, and was the 681st registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →330 of the 1,423 studies in Cognitive Dysfunction with a site in United States are open now. Recruiting first, the newest first:
National Institute of Mental Health (NIMH) · Sites in United States
Ages 50–100 · Healthy volunteers
Prevention Research Consortium Corp. · Sites in United States
Ages 55+ · Healthy volunteers
University of California, San Francisco · Sites in United States
Ages 65+
University of Pittsburgh · Sites in United States
Ages 65+
The University of Texas Medical Branch, Galveston · Sites in United States
Ages 50–100 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 40 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
1,423 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 126 · Phase 2 234 · Phase 3 54 · Phase 4 58
First in 1993; this study’s year is marked. 89 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 253 is above the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 59 across the 1,147 interventional studies, 150 across the 271 observational. Of the 890 that completed or were terminated, 379 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
209 of 1,423 have an industry lead sponsor. The 10 most frequent:
University of California, San Diego is the lead sponsor of 980 studies on the registry; 194 are open to participants now.
Of its 113 completed or terminated interventional studies of FDA-regulated products, 71 (63%) have results posted.
University of California, San Diego has 9 studies filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
173 of the studies in Cognitive Dysfunction with a site in United States that are under way reach primary completion within a year, 4 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03860857Phase 3University of California, IrvineBiomarker Exploration in Aging, Cognition and Neurodegeneration | 2026-12-22 |
| NCT03887455Phase 3Eisai Inc.A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease | 2026-12-31 |
| NCT06191965Phase 3Mclean HospitalMitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction | 2027-01-31 |
| NCT06950190Phase 3Ellis MedicineEvaluating Cognitive Changes on Patients in Chemotherapy (ECCPC) | 2027-02-20 |
| NCT03560960Boston UniversityMulti-Center Development of a Novel Diagnostic Test for Alzheimer's Disease | 2026-11 |
Add all 173 to your calendar (.ics) → With an account.
Among the 1,423 studies in Cognitive Dysfunction with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.
Many breast cancer survivors experience problems with mental abilities such as memory, attention, and concentration (known as cognition). Increasing physical activity has been shown to improve cognition in adults; however, little is known about whether this is helpful for cancer survivors as well. This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This arm will receive a 12-month individually tailored phone and email-based exercise program.
Behavioral: Exercise
This arm will receive a 12-month health and wellness program.
Behavioral: Control
This intervention is based on Control Theory and Social Cognitive Theory and includes: 1) weekly emails with tips and tools to set personalized exercise goals and to increase exercise; 2) Health coaching phone sessions; 3) wrist worn monitor such as a Fitbit to track activity
This intervention includes: 1) weekly emails with tips and tools to support health and wellness such as brain health, stress management, nutrition; 2) Health coaching phone sessions
National Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digit Test
The NIH Toolbox Oral Symbol Digit Test is a measure of processing speed, administered on an iPad by trained staff. Participants view a key pairing nine abstract symbols with the digits 1-9 and say aloud the digit that matches each symbol in a series, completing as many items as possible in 120 seconds. Higher scores indicate faster processing speed.
Time frame: Baseline to 6 months
National Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digital Test
The NIH Toolbox Oral Symbol Digit Test is a measure of processing speed, administered on an iPad by trained staff. Participants view a key pairing nine abstract symbols with the digits 1-9 and say aloud the digit that matches each symbol in a series, completing as many items as possible in 120 seconds. Higher scores indicate faster processing speed.
Time frame: Baseline to 12 months
Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Abilities
Patient-Reported Outcomes Measurement Information System (PROMIS) Item Bank v2.0 - Cognitive Function - Abilities Subset, administered as a computerized adaptive test (CAT), which assesses self-perceived cognitive abilities (e.g., memory, attention, and concentration) in daily life. Raw scores are converted to T-scores, standardized to a mean of 50 and standard deviation of 10 in the U.S. general population reference sample. Higher T-scores indicate better self-reported cognitive function.
Time frame: Baseline to 6 months and Baseline to 12 months
| Milestone | Exercise Intervention | Health & Wellness Intervention |
|---|---|---|
| Started | 127 | 126 |
| Completed | 119 | 118 |
| Not completed | 8 | 8 |
The NIH Toolbox Oral Symbol Digit Test is a measure of processing speed, administered on an iPad by trained staff. Participants view a key pairing nine abstract symbols with the digits 1-9 and say aloud the digit that matches each symbol in a series, completing as many items as possible in 120 seconds. Higher scores indicate faster processing speed.
| number of correct responses | Exercise Intervention | Health & Wellness Intervention |
|---|---|---|
| Baseline | 77 ± 1.31 | 77.2 ± 1.32 |
| 6 month | 81.5 ± 1.32 | 81.5 ± 1.33 |
The NIH Toolbox Oral Symbol Digit Test is a measure of processing speed, administered on an iPad by trained staff. Participants view a key pairing nine abstract symbols with the digits 1-9 and say aloud the digit that matches each symbol in a series, completing as many items as possible in 120 seconds. Higher scores indicate faster processing speed.
| number of correct responses | Exercise Intervention | Health & Wellness Intervention |
|---|---|---|
| Baseline | 77.0 ± 1.31 | 77.2 ± 1.32 |
| 12 month | 82.6 ± 1.33 | 83.6 ± 1.33 |
Patient-Reported Outcomes Measurement Information System (PROMIS) Item Bank v2.0 - Cognitive Function - Abilities Subset, administered as a computerized adaptive test (CAT), which assesses self-perceived cognitive abilities (e.g., memory, attention, and concentration) in daily life. Raw scores are converted to T-scores, standardized to a mean of 50 and standard deviation of 10 in the U.S. general population reference sample. Higher T-scores indicate better self-reported cognitive function.
| T-score | Exercise Intervention | Health & Wellness Intervention |
|---|---|---|
| Baseline | 43.9 ± 0.68 | 43.0 ± 0.69 |
| 6 month | 48.1 ± 0.69 | 47.0 ± 0.70 |
| 12 month | 49.9 ± 0.70 | 48.0 ± 0.70 |
Collected over 12 month study duration. Non-serious events are listed at a 5% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Exercise Intervention | 0/127 (0%) | 1/127 (0.8%) | 13/127 (10.2%) |
| Health & Wellness Intervention | 0/126 (0%) | 0/126 (0%) | 1/126 (0.8%) |
| Event | Exercise Intervention | Health & Wellness Intervention |
|---|---|---|
| FractureMusculoskeletal and connective tissue disorders | 1/127 | 0/126 |
| Event | Exercise Intervention | Health & Wellness Intervention |
|---|---|---|
| Muscle PainMusculoskeletal and connective tissue disorders | 13/127 | 1/126 |
| Age, Continuous(years) | Exercise Intervention | Health & Wellness Intervention | Total |
|---|---|---|---|
| Mean | 59.29 ± 8.99 | 57.73 ± 8.67 | 58.51 ± 8.85 |
| Sex: Female, Male(Participants) | Exercise Intervention | Health & Wellness Intervention | Total |
|---|---|---|---|
| Female | 127 | 126 | 253 |
| Male | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Exercise Intervention | Health & Wellness Intervention | Total |
|---|---|---|---|
| American Indian or Alaska Native | 1 | 2 | 3 |
| Asian | 12 | 15 | 27 |
| Native Hawaiian or Other Pacific Islander | 0 | 1 | 1 |
| Black or African American | 4 | 4 | 8 |
| White | 101 | 93 | 194 |
| More than one race | 2 | 3 | 5 |
| Unknown or Not Reported | 7 | 8 | 15 |
| Ethnicity (NIH/OMB)(Participants) | Exercise Intervention | Health & Wellness Intervention | Total |
|---|---|---|---|
| Hispanic or Latino | 21 | 20 | 41 |
| Not Hispanic or Latino | 106 | 106 | 212 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Region of Enrollment(participants) | Exercise Intervention | Health & Wellness Intervention | Total |
|---|---|---|---|
| United States | 127 | 126 | 253 |
| Body Mass Index (BMI)(kg/m2) | Exercise Intervention | Health & Wellness Intervention | Total |
|---|---|---|---|
| Mean | 29.99 ± 6.85 | 28.77 ± 5.36 | 29.38 ± 6.17 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Sep 2019 to primary completion in Jan 2024, 52 months.
Results were first posted in Nov 2026, 2 years 9 months after primary completion.
Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's 52 months is above that.
Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
Completion moved once since we started tracking on Sep 25, 2026: Feb 2025 → Oct 2025, on Nov 13, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Diego →